Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Lawrence Kleinberg. (2016) Polifeprosan 20, 3.85% carmustine slow release wafer in malignant glioma: patient selection and perspectives on a low-burden therapy. Patient Preference and Adherence 10, pages 2397-2406.
Read now
Read now
Jie Zhang, Mengxing Chen, Yiwen Zhang, Lili Zhao, Rong Yan & Kesheng Dai. (2015) Carmustine induces platelet apoptosis. Platelets 26:5, pages 437-442.
Read now
Read now
Sanjay Dixit, Mohan Hingorani, Shailendra Achawal & Ian Scott. (2011) The sequential use of carmustine wafers (Gliadel®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review. British Journal of Neurosurgery 25:4, pages 459-469.
Read now
Read now
Articles from other publishers (32)
Ilaria Cristofaro, Chiara Limongi, Paola Piscopo, Alessio Crestini, Claudia Guerriero, Mario Fiore, Luciano Conti, Annamaria Confaloni & Ada Maria Tata. (2020) M2 Receptor Activation Counteracts the Glioblastoma Cancer Stem Cell Response to Hypoxia Condition. International Journal of Molecular Sciences 21:5, pages 1700.
Crossref
Crossref
Anoop Kumar & Jonathan Pillai. 2018. Nanostructures for the Engineering of Cells, Tissues and Organs. Nanostructures for the Engineering of Cells, Tissues and Organs
473
511
.
Steffi Urbschat, Christoph Sippl, Jana Engelhardt, Kai Kammers, Joachim Oertel & Ralf Ketter. (2017) Importance of biomarkers in glioblastomas patients receiving local BCNU wafer chemotherapy. Molecular Cytogenetics 10:1.
Crossref
Crossref
A. Roux, F. Caire, J. Guyotat, P. Menei, P. Metellus & J. Pallud. (2017) Carmustine wafer implantation for high-grade gliomas: Evidence-based safety efficacy and practical recommendations from the Neuro-oncology Club of the French Society of Neurosurgery. Neurochirurgie 63:6, pages 433-443.
Crossref
Crossref
Abdur Rauf Khan, Mengrui Liu, Muhammad Wasim Khan & Guangxi Zhai. (2017) Progress in brain targeting drug delivery system by nasal route. Journal of Controlled Release 268, pages 364-389.
Crossref
Crossref
Alexandre Roux, Sophie Peeters, Marc Zanello, Rabih Bou Nassif, Georges Abi Lahoud, Edouard Dezamis, Eduardo Parraga, Emmanuelle Lechapt-Zalcmann, Frédéric Dhermain, Sarah Dumont, Guillaume Louvel, Fabrice Chretien, Xavier Sauvageon, Bertrand Devaux, Catherine Oppenheim & Johan Pallud. (2017) Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice. Journal of Neuro-Oncology 135:1, pages 83-92.
Crossref
Crossref
Paulo A. Garcia, Bor Kos, John H. RossmeislJr.Jr., Denis Pavliha, Damijan Miklavčič & Rafael V. Davalos. (2017) Predictive therapeutic planning for irreversible electroporation treatment of spontaneous malignant glioma. Medical Physics 44:9, pages 4968-4980.
Crossref
Crossref
Johan Pallud, Etienne Audureau, Georges Noel, Robert Corns, Emmanuèle Lechapt-Zalcman, Julien Duntze, Vladislav Pavlov, Jacques Guyotat, Phong Dam Hieu, Pierre-Jean Le Reste, Thierry Faillot, Claude-Fabien Litre, Nicolas Desse, Antoine Petit, Evelyne Emery, Jimmy Voirin, Johann Peltier, François Caire, Jean-Rodolphe Vignes, Jean-Luc Barat, Olivier Langlois, Edouard Dezamis, Eduardo Parraga, Marc Zanello, Edmond Nader, Michel Lefranc, Luc Bauchet, Bertrand Devaux, Philippe Menei & Philippe Metellus. (2015) Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort. Neuro-Oncology 17:12, pages 1609-1619.
Crossref
Crossref
Christopher B. Arena, Paulo A. Garcia, Michael B. Sano, John D. Olson, Thomas Rogers-Cotrone, John H. RossmeislJr.Jr. & Rafael V. Davalos. (2014) Focal blood-brain-barrier disruption with high-frequency pulsed electric fields. TECHNOLOGY 02:03, pages 206-213.
Crossref
Crossref
Laura Saenz del Burgo, Rosa María Hernández, Gorka Orive & Jose Luis Pedraz. (2014) Nanotherapeutic approaches for brain cancer management. Nanomedicine: Nanotechnology, Biology and Medicine 10:5, pages e905-e919.
Crossref
Crossref
Paulo A. Garcia, John H. RossmeislJr.Jr., Thomas L. Ellis & Rafael V. Davalos. 2014. Tumors of the Central Nervous System, Volume 12. Tumors of the Central Nervous System, Volume 12
171
182
.
Tareq A Juratli, Gabriele Schackert & Dietmar Krex. (2013) Current status of local therapy in malignant gliomas — A clinical review of three selected approaches. Pharmacology & Therapeutics 139:3, pages 341-358.
Crossref
Crossref
Zhao Yang, Tianzhi Zhao & Yong Liu. (2013) Upregulation of tumor suppressor WWOX promotes immune response in glioma. Cellular Immunology 285:1-2, pages 1-5.
Crossref
Crossref
Andrea Salmaggi, Ida Milanesi, Antonio Silvani, Paola Gaviani, Marcello Marchetti, Laura Fariselli, Carlo Lazzaro Solero, Carmelo Maccagnano, Cecilia Casali, Sara Guzzetti, Bianca Pollo, Emilio Ciusani & Francesco DiMeco. (2013) Prospective study of carmustine wafers in combination with 6-month metronomic temozolomide and radiation therapy in newly diagnosed glioblastoma: preliminary results. Journal of Neurosurgery 118:4, pages 821-829.
Crossref
Crossref
Lutz Dörner, Ahmad Mustafa, Axel Rohr, H. Maximilian Mehdorn & Arya Nabavi. (2013) Growth pattern of tumor recurrence following bis-chloroethylnitrosourea (BCNU) wafer implantation in malignant glioma. Journal of Clinical Neuroscience 20:3, pages 429-434.
Crossref
Crossref
Yu-Ling Lin, Wen-Lin Lai, Horng-jyh Harn, Pei-Hsiu Hung, Ming-Chang Hsieh, Kai-Fu Chang, Xiao-Fan Huang, Kuang-Wen Liao, Ming-Shih Lee & Nu-Man Tsai. (2013)
The Methanol Extract of
Angelica sinensis
Induces Cell Apoptosis and Suppresses Tumor Growth in Human Malignant Brain Tumors
. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-9.
Crossref
Crossref
Daniela Allhenn, Maryam Alsadat Shetab Boushehri & Alf Lamprecht. (2012) Drug delivery strategies for the treatment of malignant gliomas. International Journal of Pharmaceutics 436:1-2, pages 299-310.
Crossref
Crossref
Bangqing Yuan, Ronghua Xian, Jianfang Ma, Yujian Chen, Chuangan Lin & Yaoming Song. (2012) Isthmin inhibits glioma growth through antiangiogenesis in vivo. Journal of Neuro-Oncology 109:2, pages 245-252.
Crossref
Crossref
Gregorio Catalán-Uribarrena, Gaizka Bilbao-Barandica, Iñigo Pomposo-Gaztelu, José Undabeitia-Huertas, Edurne Ruiz de Gopegui-Ruiz, Lara Galbarriatu-Gutiérrez, Manuel Canales-Llantada, Jon Aurrecoechea-Obieta, Alfonso Igartua-Azkune & Guillermo Carbayo-Lozano. (2011) Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis. Acta Neurochirurgica 154:2, pages 211-222.
Crossref
Crossref
Carmelo Lucio Sturiale, Giovanni Sabatino, Alessio Albanese, Mario Balducci, Libero Lauriola, Ilaria Pennacchia & Giulio Maira. (2011) Subcutaneous malignant melanoma of the scalp surgical flap after brain irradiation for anaplastic astrocytoma. Journal of Neuro-Oncology 106:1, pages 203-207.
Crossref
Crossref
Andrea Salmaggi, Stefania Duri, Antonio Silvani, Paola Gaviani, Ida Milanesi, Cecilia Casali & Francesco Di Meco. (2011) Loco-regional treatments in first-diagnosis glioblastoma: literature review on association between Stupp protocol and Gliadel. Neurological Sciences 32:S2, pages 241-245.
Crossref
Crossref
Jeong Mi An, Seon Sook Kim, Jin Hak Rhie, Dong Min Shin, Su Ryeon Seo & Jeong Taeg Seo. (2011) Carmustine induces ERK- and JNK-dependent cell death of neuronally-differentiated PC12 cells via generation of reactive oxygen species. Toxicology in Vitro 25:7, pages 1359-1365.
Crossref
Crossref
Carlo Buonerba, Giuseppe Di Lorenzo, Alfredo Marinelli, Piera Federico, Giovannella Palmieri, Martina Imbimbo, Pio Conti, Gianfranco Peluso, Sabino De Placido & John H. Sampson. (2011) A comprehensive outlook on intracerebral therapy of malignant gliomas. Critical Reviews in Oncology/Hematology 80:1, pages 54-68.
Crossref
Crossref
Michelina Festa, Luis Del Valle, Kamel Khalili, Renato Franco, Giosuè Scognamiglio, Vincenzo Graziano, Vincenzo De Laurenzi, Maria Caterina Turco & Alessandra Rosati. (2011) BAG3 Protein Is Overexpressed in Human Glioblastoma and Is a Potential Target for Therapy. The American Journal of Pathology 178:6, pages 2504-2512.
Crossref
Crossref
Chyou-Wei Wei, Pei-Lun Chou, Yu-Ting Hung & Giou-Teng Yiang. (2011) Synergistic cytotoxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea and Rana catesbeiana ribonuclease-6 in hepatoma cells. Tzu Chi Medical Journal 23:1, pages 9-15.
Crossref
Crossref
P. A. GarciaT. PancottoJ. H. RossmeislJr.Jr., N. Henao-Guerrero, N. R. Gustafson, G. B. Daniel, J. L. Robertson, T. L. Ellis & R. V. Davalos. (2011) Non-Thermal Irreversible Electroporation (N-TIRE) and Adjuvant Fractionated Radiotherapeutic Multimodal Therapy for Intracranial Malignant Glioma in a Canine Patient. Technology in Cancer Research & Treatment 10:1, pages 73-83.
Crossref
Crossref
Andrej Vranic. (2011) New developments in surgery of malignant gliomas. Radiology and Oncology 45:3.
Crossref
Crossref
Hui-Fang Chang, Wen-Tsung Huang, Hui-Ju Chen & Ling-Ling Yang. (2010) Apoptotic Effects of γ-Mangostin from the Fruit Hull of Garcinia mangostana on Human Malignant Glioma Cells. Molecules 15:12, pages 8953-8966.
Crossref
Crossref
Javier Márquez-Rivas, Gema Ramirez, Ángela Ollero-Ortiz, Jorge Giménez-Pando, Juan Emmerich, Eduardo Quiroga-Cantero, Eloy Rivas & Emilio Gómez-González. (2010) Initial Experience Involving Treatment and Retreatment With Carmustine Wafers in Combination With Oral Temozolomide: Long-term Survival in a Child With Relapsed Glioblastoma Multiforme. Journal of Pediatric Hematology/Oncology 32:5, pages e202-e206.
Crossref
Crossref
Pei-Chih Lee, Rajesh Kakadiya, Tsann-Long Su & Te-Chang Lee. (2010) Combination of Bifunctional Alkylating Agent and Arsenic Trioxide Synergistically Suppresses the Growth of Drug-Resistant Tumor Cells. Neoplasia 12:5, pages 376-IN2.
Crossref
Crossref
Anna-Karin Larsson, Abeer Shokeer & Bengt Mannervik. (2010) Molecular evolution of Theta-class glutathione transferase for enhanced activity with the anticancer drug 1,3-bis-(2-chloroethyl)-1-nitrosourea and other alkylating agents. Archives of Biochemistry and Biophysics 497:1-2, pages 28-34.
Crossref
Crossref
Anne Balossier, Lutz Dörner, Evelyne Emery, Oliver Heese, H. Maximilian Mehdorn, Philippe Menei & Jagmohan Singh. (2010) Incorporating BCNU Wafers into Malignant Glioma Treatment. Clinical Drug Investigation 30:3, pages 195-204.
Crossref
Crossref